US 7718612
Pyridazinonyl macrocyclic hepatitis C serine protease inhibitors
granted A61KA61K38/21A61K45/06
Quick answer
US patent 7718612 (Pyridazinonyl macrocyclic hepatitis C serine protease inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K38/21, A61K45/06, A61P, A61P31/00